Cost of stroke in Canada: A 1-year prospective study

Journal of Medical Economics

Volumn 8, Issue 42008, 2005, Pages 147-167

  Goeree, Ron ^a,b   Blackhouse, Gord ^a,b   Petrovic, Radmila ^c   Salama, Suzette ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Canada; cost and cost analysis; direct service cost; healthcare costs; stroke

Indexed keywords

EID: 85012904954     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/200508147167     Document Type: Article

References (81)

1. Kaste M, Fogelholm R, Rissanen A. Economic burden of stroke and the evaluation of new therapies. Public Health 1998; 112: 103 – 112.
2. American Stroke Association. Available at: www.strokeassociation.org [accessed 14 November 2005].
3. Dobkin B. The economic impact of stroke. Neurology 1995; 45 (2 Suppl 1): S6–S9.
4. Horner RD. The high cost of stroke to society, the family, and the patient. Pharmacotherapy 1998; 18: 87S–93S.
5. Heart and Stroke Foundation of Canada. Stroke statistics. Available at: http://ww2. heartandstroke.ca/Page.asp?PageID=33&Arti cleID=428&Src=stroke&From=SubCategory [accessed 14 November 2005].
6. Giroud M, Milan C, Beuriat P et al. Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985–1989. International Journal of Epidemiology 1991; 20: 892 – 899.
7. Anderson CS, Jamrozik KD, Burvill PW et al. Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke Study, 1989–1990. Medical Journal of Australia 1993; 158: 85 – 89.
8. Hachinski V. Stroke: the next 30 years. Stroke 2002; 33: 1 – 4.
9. World Health Organization. The World Health Report. Geneva, Switzerland, 1999.
10. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436 – 1442.
11. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269 – 1276.
12. Bamford J, Sandercock P, Dennis M et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project — 1981–86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. Journal of Neurology, Neurosurgery, and Psychiatry 1990; 53: 16 – 22.
13. Evers SM, Engel GL, Ament AJ. Cost of stroke in The Netherlands from a societal perspective. Stroke 1997; 28: 1375 – 1381.
14. Dewey HM, Thrift AG, Mihalopoulos C et al. Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2001; 32: 2409 – 2416.
15. Scott WG, Scott H. Ischaemic stroke in New Zealand: an economic study. New Zealand Medical Journal 1994; 107: 443 – 446.
16. Terent A, Marke LA, Asplund K et al. Costs of stroke in Sweden. A national perspective. Stroke 1994; 25: 2363 – 2369.
17. Drummond M, Ward G. The financial burden of stroke and the economic evaluation of treatment alternatives. In: Rose FC, Editor. Stroke: epidemiological, therapeutic and socioeconomic aspects. London, UK: Royal Society of Medicine Services, 1986: 147 – 162.
18. Isard P, Forbes J. The cost of stroke to the National Health Service in Scotland. Cerebrovascular Diseases 1992; 2: 47 – 50.
19. Matchar D, Duncan P. The cost of stroke. Stroke Clinical Updates 1994; 5 (3): 9 – 12.
20. Berk A, Paringer L, Mushkin SJ. The economic cost of illness: fiscal 1975. Medical Care 1978; 16: 785 – 790.
21. Taylor TN, Davis PH, Torner JC et al. Lifetime cost of stroke in the United States. Stroke 1996; 27: 1459 – 1466.
22. Mills E, Thompson M. The economic costs of stroke in Massachusetts. New England Journal of Medicine 1978; 299: 415 – 418.
23. Hartunian NS, Smart CN, Thompson MS. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis. American Journal of Public Health 1980; 70: 1249 – 1260.
24. Adelman SM. The National Survey of Stroke: economic impact. Stroke 1981; 12(2 Pt 2 Suppl 1): I69–I87.
25. Dombovy ML, Sandok BA, Basford JR. Rehabilitation for stroke: a review. Stroke 1986; 17: 363 – 369.
26. Hodgson TA, Cohen AJ. Medical expenditures for major diseases, 1995. Health Care Financing Review 1999; 21: 119 – 164.
27. Weill C, Schneider T. The cost of cerebrovascular accidents in France in 1982. In: Rose FC, Editor. Stroke: epidemiological, therapeutic and socioeconomic aspects. London, UK: Royal Society of Medicine Services Ltd., 1986.
28. Bergman L, van der Meulen JH, Limburg M et al. Costs of medical care after first-ever stroke in The Netherlands. Stroke 1995; 26: 1830 – 1836.
29. Koopmanschap MA, van Roijen L, Bonneux L. Costs of illness in the Netherlands. Rotterdam, The Netherlands: Instituut Maatschappelijke Gezondheidszorg Instituut voor Medische Techonology Assessment Erasmus Universiteit Rotterdam, 1991.
30. Chan B, Hayes B. Cost of Stroke in Ontario, 1994/95. Canadian Medical Association Journal 1998; 159 (6 Suppl): S2 – S7.
31. Moore R, Mao Y, Zhang J et al. Economic burden of illness in Canada, 1993. Ottawa, Canada: Health Canada, 1997.
32. Health Canada. Economic burden of illness in Canada, 1998. Ottawa, Canada: Health Canada, 2002.
33. Porsdal V, Boysen G. Cost-of-illness studies of stroke. Cerebrovascular Diseases 1997; 7: 258 – 263.
34. Evers SM, Ament AJ, Blaauw G. Economic evaluation in stroke research: a systematic review. Stroke 2000; 31: 1046 – 1053.
35. Evers SM, Goossens ME, Ament AJ et al. Economic evaluation in stroke research: an introduction. Cerebrovascular Diseases 2001; 11: 82 – 91.
36. Hodgson TA, Cohen AJ. Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures. Medical Care 1999; 37: 994 – 1012.
37. Persson U, Silverberg R, Lindgren B et al. Direct costs of stroke for a Swedish population. International Journal of Technology Assessment in Health Care 1990; 6: 125 – 137.
38. Grieve R, Porsdal V, Hutton J et al. A comparison of the cost-effectiveness of stroke care provided in London and Copenhagen. International Journal of Technology Assessment in Health Care 2000; 16: 684 – 695.
39. Andersson A, Levin LA, Oberg B et al. Health care and social welfare costs in home-based and hospital-based rehabilitation after stroke. Scandinavian Journal of Caring Sciences 2002; 16: 386 – 392.
40. Weimar C, Weber C, Wagner M et al. Management patterns and health care use after intracerebral hemorrhage. A cost-of- illness study from a societal perspective in Germany. Cerebrovascular Diseases 2003; 15: 29 – 36.
41. van Exel J, Koopmanschap MA, Van Wijngaarden JD et al. Costs of stroke and stroke services: determinants of patient costs and a comparison of costs of regular care and care organised in stroke services. Cost Effectiveness and Resource Allocation 2003; 1: 2.
42. Spieler JF, Lanoe JL, Amarenco P. Socioeconomic aspects of postacute care for patients with brain infarction in France. Cerebrovascular Diseases 2002; 13: 132 – 141.
43. Porsdal V, Boysen G. Direct costs during the first year after intracerebral hemorrhage. European Journal of Neurology 1999; 6: 449 – 454.
44. Ghatnekar O, Persson U, Glader EL et al. Cost of stroke in Sweden: an incidence estimate. International Journal of Technology Assessment in Health Care 2004; 20: 375 – 380.
45. Carod-Artal FJ, Egido-Navarro JA, Gonzalez- Gutierrez JL et al. [Direct cost of cerebrovascular disease during the first year of follow-up]. Revista de Neurologia 1999; 28: 1123–1130 [in Spanish].
46. Claesson L, Gosman-Hedstrom G, Johannesson M et al. Resource utilization and costs of stroke unit care integrated in a care continuum: a 1-year controlled, prospective, randomized study in elderly patients: the Goteborg 70+ Stroke Study. Stroke 2000; 31: 2569 – 2577.
47. Dodel RC, Haacke C, Zamzow K et al. Resource utilization and costs of stroke unit care in Germany. Value in Health 2004; 7: 144 – 152.
48. Levy E, Gabriel S, Dinet J. The comparative medical costs of atherothrombotic disease in European countries. PharmacoEconomics 2003; 21: 651 – 659.
49. Patel A, Knapp M, Perez I et al. Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial. Stroke 2004; 35: 196 – 203.
50. Zethraeus N, Molin T, Henriksson P et al. Costs of coronary heart disease and stroke: the case of Sweden. Journal of Internal Medicine 1999; 246: 151 – 159.
51. Terent A. Medico-social consequences and direct costs of stroke in a Swedish community. Scandinavian Journal of Rehabilitation Medicine 1983; 15: 165 – 171.
52. Truelsen T, Ekman M, Boysen G. Cost of stroke in Europe. European Journal of Neurology 2005; 12(Suppl 1): 78 – 84.
53. World Currency Exchange Rates. Available at: http://www.exchange-rates.org [accessed 14 November 2005].
54. Payne KA, Huybrechts KF, Caro JJ et al. Long term cost-of-illness in stroke: an international review. PharmacoEconomics 2002; 20: 813 – 825.
55. Smurawska LT, Alexandrov AV, Bladin CF et al. Cost of acute stroke care in Toronto, Canada. Stroke 1994; 25: 1628 – 1631.
56. Porsdal V, Boysen G. Costs of health care and social services during the first year after ischemic stroke. International Journal of Technology Assessment in Health Care 1999; 15: 573 – 584.
57. Holloway RG, Witter Jr DM, Lawton KB et al. Inpatient costs of specific cerebrovascular events at five academic medical centers. Neurology 1996; 46: 854 – 860.
58. Leibson CL, Hu T, Brown RD et al. Utilization of acute care services in the year before and after first stroke: a population-based study. Neurology 1996; 46: 861 – 869.
59. Mamoli A, Censori B, Casto L et al. An analysis of the costs of ischemic stroke in an Italian stroke unit. Neurology 1999; 53: 112 – 116.
60. Martinez-Vila E, Irimia P. The cost of stroke. Cerebrovascular Diseases 2004; 17(Suppl 1): 124 – 129.
61. Gerzeli S, Tarricone R, Zolo P et al. The economic burden of stroke in Italy. The EcLIPSE Study: Economic Longitudinal Incidence-based Project for Stroke Evaluation. Neurological Sciences 2005; 26: 72 – 80.
62. Thorngren M, Westling B. Utilization of health care resources after stroke. A population- based study of 258 hospitalized cases followed during the first year. Acta Neurolica Scandinavica 1991; 84: 303 – 310.
63. Reed SD, Blough DK, Meyer K et al. Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals. Neurology 2001; 57: 305 – 314.
64. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Maryland State Medical Journal 1965; 14: 61 – 65.
65. Collin C, Wade DT, Davies S et al. The Barthel ADL Index: a reliability study. International Disability Studies 1998; 10: 61 – 63.
66. Bonita R, Beaglehole R. Modification of Rankin Scale: recovery of motor function after stroke. Stroke 1988; 19: 1497 – 1500.
67. Caro JJ, Huybrechts KF, Kelley HE. Predicting treatment costs after acute ischemic stroke on the basis of patient characteristics at presentation and early dysfunction. Stroke 2001; 32: 100 – 106.
68. Jorgensen HSN. Acute stroke care and rehabilitation: an analysis of the direct cost and its clinical and social determinants. The Copenhagen Stroke Study. Stroke 1997; 28: 1138 – 1141.
69. van SA, van der Meulen JH, van den Bos GA et al. Length of hospital stay and discharge delays in stroke patients. Stroke 1997; 28: 137 – 140.
70. Salama S, Petrovic R, Goeree R, Blackhouse G. One year follow up of pharmacoeconomics and clinical outcomes of hospitalized stroke patients in Hamilton, Canada [abstract 37] Cerebrovas Dis 2003; 16 (suppl 4): 158
71. Hamilton Health Sciences. Available at: www.hamiltonhealthsciences.ca [accessed 14 November 2005].
72. ICD-9. International Classification of Diseases, 9th edn. Available at: http://www.cdc.gov/ nchs/about/otheract/icd9/abticd9.htm [accessed 14 November 2005].
73. Ontario Case Costing Initiative (OCCI). Available at: http://www.occp.com [accessed 14 November 2005].
74. Ontario Case Cost Project. Ontario Case Cost Project (OCCP): Ontario Guide to Case Costing, Version 1.1. Ottawa, Canada: Ontario Case Cost Project, 1995.
75. Jacobs P, Assiff L, Backynsky J et al. A national list of provincial costs for health care: Canada 1997/98. Edmonton, Alberta, Canada: Institute of Health Economics, 2000.
76. Ontario Ministry of Health. Ontario Drug Benefit Formulary. Ottawa, Canada: Ministry of Health, 2004.
77. Ontario Ministry of Health. Ontario Drug Benefit Formulary/Comparative Drug Index. Available at: http://www.health.gov.on.ca/ english/providers/program/drugs/odbf_ mn.html [accessed 14 November 2005].
78. Ontario Ministry of Health and Long Term Care. Ontario Health Insurance Plan (OHIP). Available at: http://www.health.gov.on.ca/ english/public/program/ohip/ohip_mn.html [accessed 14 November 2005]. 78. Schedule of Benefits for Physician Services under the Health Insurance Act. Ottawa, Canada: Ontario Ministry of Health and Long Term Care, 2005.
79. Statistics Canada. Table 282-0700 — Labour force survey estimates (LFS), wages of employees by type of work, National Occupation Classification for Statistics (NOC-S), sex and age group, annual. Available at: http://estat.statcan.ca/ [accessed 14 November 2005].
80. Fogelholm R, Hernesniemi J, Vapalahti M. Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke 1993; 24: 1649 – 1654.
81. Diez-Tejedor E, Fuentes B. Acute care in stroke: do stroke units make the difference? Cerebrovascular Diseases 2001; 11(Suppl 1): 31 – 39.